Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclic AMP and cyclic GMP in hyperresponsiveness.

H T Miller1, W Yesus, T Cooper

  • 1Department of Natural Sciences and Mathematics, Lincoln University, Jefferson City, Missouri 65101.

Life Sciences
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracranial arachnoid cyst in pregnancy: case report, literature review and evaluation of neuraxial anaesthesia risk.

International journal of obstetric anesthesia·2023
Same author

The role of pandemic planning in the management of COVID-19 in England from an infection prevention and control perspective: results of a national survey.

Public health·2023
Same author

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
Same author

Oral and Maxillofacial Surgery and Oral Surgery - what's the difference? A Western Australian dental student survey.

The British journal of oral & maxillofacial surgery·2020
Same author

Magnetic resonance imaging for three-dimensional printing of the bony orbit: is clinical use imminent?

International journal of oral and maxillofacial surgery·2019
Same author

The relationship between an electronic mental health stigma campaign and suicidal thoughts and behaviours: a two-arm randomized controlled trial in the Australian construction industry.

Health promotion international·2019
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
Same journal

SLC30A9-mediated mitochondrial zinc homeostasis drives osteosarcoma chemoresistance by suppressing the mtDNA-cGAS-STING pathway.

Life sciences·2026
See all related articles

Cyclic-AMP amplifies blood pressure responses to norepinephrine in rats, a effect blocked by angiotensin II antagonists. Cyclic-GMP, however, causes a decrease in blood pressure, indicating distinct mechanisms.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology
  • Cell Signaling

Background:

  • Cyclic adenosine monophosphate (cAMP) is known to potentiate norepinephrine-induced blood pressure changes.
  • The precise mechanisms underlying cAMP's influence on cardiovascular responses require further elucidation.

Purpose of the Study:

  • To investigate the role of angiotensin II in mediating the blood pressure hyperresponse induced by cAMP.
  • To explore the effects of cyclic guanosine monophosphate (cGMP) on norepinephrine-induced blood pressure changes.

Main Methods:

  • Experiments were conducted using anesthetized rats.
  • Administration of norepinephrine, cyclic-AMP (cAMP), cyclic-GMP (cGMP), and the angiotensin II antagonist Sar1-Thr8 angiotensin II.
  • Monitoring of blood pressure changes.

Related Experiment Videos

Main Results:

  • Cyclic-AMP (cAMP) caused a hyperresponse in blood pressure when combined with norepinephrine.
  • The angiotensin II antagonist Sar1-Thr8 angiotensin II abolished the cAMP-induced hyperresponse, which returned upon antagonist removal.
  • Cyclic-GMP (cGMP) prevented the cAMP-induced hyperresponse and instead caused a decrease in blood pressure, suggesting vascular smooth muscle relaxation.

Conclusions:

  • The hyperresponse to cAMP in conjunction with norepinephrine appears to be mediated by angiotensin II.
  • Cyclic-GMP (cGMP) exerts distinct cardiovascular effects, potentially through vascular smooth muscle relaxation.
  • Cyclic-AMP and cyclic-GMP utilize different mechanisms to modulate cardiovascular responses.